Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 425 of 574 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 05/01/30
Due: 05/01/31
Phase: N/A
Priority: Normal
Start: 12/29/16
End: 06/06/19
Due: 06/06/20
Phase: N/A
Priority: Normal
Start: 02/27/18
End: 05/31/19
Due: 05/31/20
Phase: N/A
Priority: Normal
Start: 12/02/22
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 08/31/23
End: 08/15/25
Due: 08/15/26
Phase: N/A
Priority: Normal
Start: 09/10/21
End: 05/17/22
Due: 05/17/23
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 07/14/20
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 09/01/17
End: 06/20/20
Due: 06/20/21
Phase: N/A
Priority: Normal
Start: 09/29/23
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 05/05/22
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 07/05/23
End: 04/26/24
Due: 04/26/25
Phase: N/A
Priority: Normal
Start: 01/04/19
End: 12/31/25
Due: 12/31/26
Clinical and Radiological Outcomes of Posterior Cervical Fusion Supplemented With Interfacet Spacers
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 10/05/23
End: 07/11/24
Due: 07/11/25
Phase: N/A
Priority: Normal
Start: 06/20/23
End: 01/01/27
Due: 01/01/28
Phase: N/A
Priority: Normal
Start: 07/11/24
End: 03/31/29
Due: 03/31/30
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 09/03/19
Due: 09/03/20
Phase: N/A
Priority: Normal
Start: 03/15/24
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 06/26/23
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 02/04/22
Due: 02/04/23